Thyroid Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Thyroid Cancer Diagnostics Market is Segmented by Disease Type (Papillary Carcinoma, Follicular Carcinoma, and Other Disease Types), Diagnostic Technique (Blood Tests, Imaging, Biopsy, and Other Diagnostic Techniques), End User (Hospital Laboratories, Cancer Diagnostic Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for all the above-mentioned segments.

Thyroid Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Thyroid Cancer Diagnostics Industry Overview

The thyroid cancer diagnostics market is highly competitive in nature, with many key players dominating the market. The presence of major market players, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., and Generic Electric, is intensifying the competition. The market players are adopting strategies like R&D, mergers, and acquisitions to sustain the increasing market rivalry.

In March 2021, Cancer Genetics and StemoniX announced the news of their merger.

Thyroid Cancer Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Siemens Healthineers

  3. ThermoFisher Scientific

  4. Illumina Inc.

  5. Eli Lilly and Company

  6. *Disclaimer: Major Players sorted in no particular order
Market concentration.png

Thyroid Cancer Diagnostics Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?